Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer

Blood

Volumn 92, Issue 10, 1998, Pages 3949-3959

  Blazar, Bruce R ^a   Taylor, Patricia A ^b   McElmurry, Ron ^b   Tian, Lina ^b   Panoskaltsis Mortari, Angela ^b   Lam, Sylvia ^b   Lees, Chris ^b   Waldschmidt, Thomas ^b   Vallera, Daniel A ^b  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ALLOGENEIC RESTRICTION; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; IMMUNOPRECIPITATION; MEMORY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECIPIENT; SCORING SYSTEM; SPLEEN CELL; TREATMENT OUTCOME;

EID: 0032533265     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3949     Document Type: Article

References (27)

1. Flake AW, Roncarolo M-G, Puck JM, Almeida-Porada G, Evans MI, Johnson MR Abella EM, Harrison DD, Zanjani ED: Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335:1806, 1996
2. Cowan MJ, Wara DW, Weintrub PS, Pabst H, Aminann AJ: Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells. J Clin Immunol 5:370, 1985
3. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Marken ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE: Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 136:2398, 1986
4. Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G, Vossen J, Wagemaker G, Landais P: Bone marrow transplantation tor immunodeficiencies and osteopetrosis: European survey, 1968-85. Lancet 2:1080, 1986
5. Moen RC, Horowitz DS, Sondel PM, Borcherding WR, Trigg ME, Billing R, Hong R: Immunologic reconstitution after haploidentical bone marrow transplantation for immunodeficiency disorders: Treatment of bone marrow cells with monoclonal antibody CT-2 and complement. Blood 70:664, 1987
6. Wijnaendts L, Le Deist F, Griscelli C, Fischer A: Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 74:2212, 1989
7. O'Reilly RJ, Keever CA, Small TN, Brochstein J: The use of HLA-non-identical T-cell depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodef Rev 1:272, 1989
8. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora, A, Gillio A, Keman NA, O'Reilly RJ: Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73:1340, 1989
9. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N: B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: A recapitulation of normal B-cell ontogeny. Blood 76:1647, 1990
10. Minegishi Y, Ishii N, Tsuchida M, Okawa H, Sugamura K, Yata J: T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID. Bone Marrow Transplant 16:801, 1995
11. Benkerrou M, Wara DW, Elder M, Dror Y, Merino A, Colombe BW, Garovoy M, Cowan MJ: Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation. J Clin Immunol 14:98, 1994
12. Dror Y, Gallagher R, Wara DW, Colombe BW, Merino A, Benkerrou M, Cowan MJ: Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 81:2021, 1993
13. Buckley RH, Schiff SE, Schiff RI, Roberts JL, Marken ML, Peters W, Williams LW, Ward FE: Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 30:92, 1993 (suppl 4)
14. van Leeuwen JEM, Van Tol MJD, Joosten AM, Schellekens PTA, van den Bergh RL, Waaijer JLM, Oudeman-Gruber NJ, van der Weijden-Ragas CPM, Roos MTL, Gerritsen EJA, van den Berg H, Haraldsson A, Khan PM, Vossen JM: Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood 84:3936, 1994
15. Parkman R, Weinberg KI: Immunological reconstitution following bone marrow transplantation. Immunol Rev 157:73, 1997
16. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky R, Vossen J: European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 2:850, 1990
17. Sanders J, Sullivan K, Witherspoon R, Doney K, Anasetti C, Beatty P, Petersen FB: Long term effects and quality of life in children and adults after marrow transplantation. Bone Marrow Transplant 4:27. 1989 (suppl)
18. Sanders JE: Growth and development after bone marrow transplantation, in Forman SJ, Blume KG. Thomas ED (eds): Bone Marrow Transplantation. Blackwell Scientific. 1994, p 527
19. Winged JR, Plotnick LP, Freemer CS, Zahurak M, Piantadosi S, Miller DF, Vriesendorp HM, Yeager AM, Santos GW: Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 79:1068, 1992
20. Blazar BR, Taylor PA, Vallera DA: In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood 86:4353, 1995
21. Blazar BR, Taylor PA, Vallera DA: Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood 85:833, 1995
22. Blazar BR, Taylor PA, Linsley PS, Vallera DA: In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex (MHC) barrier in mice. Blood 83:3815, 1994
23. Bunting KD, Sangster MY, Ihle JN, Sorrentino BP: Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviralmediated gene transfer. Nat Med 4:58, 1998
24. Zanjani ED, Almeida-Porada G, Ascensao JL, MacKintosh FR, Flake AW: Transplantation of hematopoietic stem cells in utero. Stem Cells 15:79, 1997 (suppl 1)
25. Archer DR, Turner CW, Yeager AM, Fleming WH: Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 90:3222, 1997
26. Howson-Jan K, Matloub YH, Vallera DA, Blazar BR: In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation 56:709, 1993
27. Carrier E, Lee TH, Busch MP, Cowan MJ: Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 86:4681, 1995